Skip to content

Effectiveness of Telerehabilitation With Trak in Knee and Shoulder Pathology: A Randomized Clinical Trial

A Randomized Clinical Trial to Evaluate the Effectiveness of Telerehabilitation With Trak in Patients With Knee or Shoulder Pathology.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06498453
Acronym
TRAK-TEST
Enrollment
40
Registered
2024-07-12
Start date
2022-03-01
Completion date
2023-06-06
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Injury, Shoulder Injury

Keywords

Telemedicine, Digital health, Telehealth care

Brief summary

The main objective of this clinical trial is to compare the effectiveness of digital physiotherapy treatment using the Trak telerehabilitation platform and the application of conventional means on two different health conditions (mild or moderate knee osteoarthritis and shoulder tendinopathy) Participants will undergo telerehabilitation treatment through the TRAK platform for six weeks (treatment group) or follow the instructions and guidelines collected by health personnel for the same time in face-to-face rehabilitation sessions (control group).

Detailed description

The recruitment process for this study is aimed at adults who suffer from musculoskeletal pathologies of the knee (mild or moderate osteoarthritis) or shoulder (tendinopathy). After the initial screening, individuals who meet the study's predefined inclusion criteria will be invited to participate. Before enrollment, written informed consent will be obtained from all participants, ensuring ethical compliance and respect for individual autonomy. The study cohort will consist of patients randomly assigned to the experimental group (EG) and the control group (CG) on both knee and shoulder groups. This randomised controlled trial has a parallel design with two groups. Regardless of group assignment, all patients will undergo baseline health assessments, ensuring that their individual needs are met. The satisfaction questionnaire will be deferred until post-intervention for both groups. Patients will undergo 4 weeks of treatment through the TRAK tool (https://www.trakphysio.com/es/). Patients from the EG will carry out the treatment through the platform at home, and those from the CG will follow an on paper exercise protocol based on the usual (in-person) clinical practice methodology. Both groups will perform exercises in these rehabilitation sessions to improve shoulder mobility. In phase 1 (3 weeks), all groups will undergo two weeks of in-person treatment based on established drainage technique and TENS application, ensuring the treatment's safety and efficacy. In addition, the patients will begin with in-person (CG) or remote treatment (EG), depending on the case. In the second phase or phase 2 (3 more weeks), patients will perform the exercises at home (EG) or at the medical center (CG). The results will be evaluated using different scales, such as the DASH scale and the KOOS-PS scale, as well as other secondary scales assessing strength, mobility, pain, and patient satisfaction. These measurements will be collected at the beginning and end of the proposed treatment. These scales will be completed on paper at the beginning and end of the study for both groups, although the daily scales (pain, mobility and strength) will be completed through the platform in the case of the treatment group.

Interventions

DEVICETrak-Physio knee condition

The exercise protocol designed for knee conditions is carried out through Trak, the digital rehabilitation tool.

DEVICETrak-Physio in shoulder condition

The exercise protocol designed for knee conditions is carried out through Trak, the digital rehabilitation tool.

Exercise protocol with the methodology of conventional clinical practice.

OTHERShoulder conventional rehabilitation program

Exercise protocol with the methodology of conventional clinical practice.

Sponsors

Trak Health Solutions S.L.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient over 18 years of age. * Patients with musculoskeletal pathology according to: Knee: patients between 50 and 70 years old with a knee injury. Among the injuries Considered include mild or moderate osteoarthrosis and knee meniscopathies. Shoulder: patients with shoulder tendonitis. * Patients with a tablet, smartphone or laptop who function agilely with the telematic technology necessary for the study. * Have an email account. * Understand the purpose of the study. * Signing of the informed consent. * Commitment to carry out the prescribed treatments.

Exclusion criteria

* Patients with advanced cognitive impairment. * Patients with tendon tears or ruptures, in patients with shoulder tendinopathy.

Design outcomes

Primary

MeasureTime frameDescription
Escala DASHBaseline and six monthsIt is used to measure the self-rated upper-extremity disability and symptoms.
Escala KOOS-PSBaseline and six monthsIt evaluates the patient's opinion about their knee and associated problems.

Secondary

MeasureTime frameDescription
Daniels scaleBaseline and six monthsIt is used to measure the patients strength on a specific movement and muscle from 0 to 5, being 0 a total paralysis and a 5 the full joint movement with a resistance.
EVA scaleBaseline and six monthsIt is used to measure the level of pain the patient feels.
Trak designed a satisfaction questionnaireBaseline and six monthsThe trak satisfaction questionnaire was provided to patients in Spanish and consists of 12 questions about usability, usefulness and satisfaction as well as a suggestions section at the end.
Limb mobilityBaseline and six monthsIt will be measured with a goniometer.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026